Felzartamab (anti-CD38) in patients with IgA Nephropathy-interim results from the IGNAZ study

被引：0
|
作者：
Floege, Juergen [1 ]
Lafayette, Richard [2 ]
Barratt, Jonathan [3 ]
Schwartz, Brian [4 ]
Manser, Paul T. [4 ]
Patel, Uptal D. [4 ]
Pineda, Lilia [4 ]
Faulhaber, Nicola [5 ]
Boxhammer, Rainer [5 ]
Haertle, Stefan [5 ]
Thakur, Anjali [5 ]
Barbour, Sean [6 ]
机构：
[1] RWTH Aachen Univ Hosp, Div Nephrol & Cardiol, Aachen, Germany
[2] Stanford Glomerular Dis Ctr, Palo Alto, CA USA
[3] Univ Leicester, Leicester, Leics, England
[4] Human Immunol Biosci Inc, San Francisco, CA USA
[5] MorphoSys AG, Planegg, Germany
[6] Univ British Columbia, Div Nephrol, Vancouver, BC, Canada
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
425
引用
收藏
页码：I252 / I253
页数：2
相关论文
共 50 条
  • [1] Immunologic Responses After COVID-19 Vaccination in Patients With Membranous Nephropathy Receiving Anti-CD38 Felzartamab Therapy: Results From the Phase 1b/2a M-PLACE Study
    Rovin, Brad H.
    Boxhammer, Rainer
    Thakur, Anjali
    Ronco, Pierre M.
    [J]. KIDNEY INTERNATIONAL REPORTS, 2022, 7 (09): : 2086 - 2090
  • [2] Atrasentan for the Treatment of IgA Nephropathy: Interim Results From the AFFINITY Study
    Rastogi, Anjay
    Rheault, Michelle N.
    Kim, Sung Gyun
    Vo, Nam D.
    Ranganathan, Dwarakanathan
    Inker, Lesley A.
    Packham, David K.
    Vishnepolsky, Mark
    Sheth, Khushboo
    DeVries, Todd
    Camargo, Marianne
    King, Andrew J.
    Jones-Burton, Charlotte
    Wong, Muh Geot
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 187 - 187
  • [3] ATRASENTAN FOR THE TREATMENT OF IGA NEPHROPATHY: INTERIM RESULTS FROM THE AFFINITY STUDY
    Kim, Sung-Gyun
    Nam Vo
    Lee, Sang-Ho
    Ranganathan, Dwarakanathan
    Inker, Lesley
    El-Shahawy, Mohamed
    Spinelli, Terri
    Sheth, Khushboo
    Devries, Todd
    Camargo, Marianne
    King, Andrew
    Glicklich, Alan
    Wong, Muh
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I816 - I817
  • [4] IMiD Retreatment in Patients Refractory to Both an IMiD and an Anti-CD38 Antibody Induces Significant Response Rates Post Anti-CD38 Exposure
    Gavriatopoulou, Maria
    Ntanasis-Stathopoulos, Ioannis
    Malandrakis, Panagiotis
    Fotiou, Despina
    Migkou, Magdalini
    Kanellias, Nikolaos
    Eleutherakis-Papaiakovou, Evangelos
    Dialoupi, Ioanna
    Theodorakakou, Foteini
    Roussou, Maria
    Terpos, Evangelos
    Kastritis, Efstathios
    Dimopoulos, Meletios A.
    [J]. BLOOD, 2020, 136
  • [5] Felzartamab in Patients with Anti-Phospholipase A2 Receptor Autoantibody Positive (Anti-PLA2R+) Membranous Nephropathy (MN): Interim Results from the M-PLACE Study
    Rovin, Brad H.
    Adler, Sharon G.
    Hoxha, Elion
    Sprangers, Ben
    Stahl, Rolf A.
    Wetzels, Jack F.
    Schwamb, Bettina
    Boxhammer, Rainer
    Quynh Nguyen
    Haertle, Stefan
    Ronco, Pierre M.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 513 - 514
  • [6] Transfusion management for patients taking an anti-CD38 monoclonal antibody
    Bub, Carolina Bonet
    dos Reis, Isabel Nagle
    Aravechia, Maria Giselda
    Santos, Leandro Dinalli
    Bastos, Eduardo Peres
    Kutner, Jose Mauro
    Castilho, Lilian
    [J]. HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2018, 40 (01) : 25 - 29
  • [7] Blood Transfusion Management for Patients Treated With Anti-CD38 Monoclonal Antibodies
    Lancman, Guido
    Arinsburg, Suzanne
    Jhang, Jeffrey
    Cho, Hearn Jay
    Jagannath, Sundar
    Madduri, Deepu
    Parekh, Samir
    Richter, Joshua
    Chari, Ajai
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [8] Antibody testing in patients treated with anti-CD38: there is still room for improvement
    Wagner, Franz F.
    [J]. BLOOD TRANSFUSION, 2020, 18 (04) : 244 - 246
  • [9] Anti-CD38 autoimmunity in patients with chronic autoimmune thyroiditis or Graves' disease
    Antonelli, A
    Fallahi, P
    Nesti, C
    Pupilli, C
    Marchetti, P
    Takasawa, S
    Okamoto, H
    Ferrannini, E
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 126 (03): : 426 - 431
  • [10] UPDATED INTERIM RESULTS OF A PHASE 1/2 STUDY OF BION-1301 IN PATIENTS WITH IGA NEPHROPATHY
    Barratt, Jonathan
    Kooienga, Laura
    Agha, Irfan
    Ruiz-Ramon, Pablo
    Madan, Arvind
    Thomas, Hanna
    Sorensen, Bess
    Leiske, Jocelyn
    Khawaja, Zeeshan
    King, Andrew
    Jones-Burton, Charlotte
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I394 - I394
12345